Pralatrexate in Chinese Patients with Relapsed or Refractory Peripheral T-cell Lymphoma: A Single-arm, Multicenter Study

BACKGROUND: Peripheral T-cell lymphoma (PTCL) is associated with poor prognosis, particularly in patients with relapsed/refractory (R/R) disease. Pralatrexate, a folate analogue inhibitor, was the first drug approved to treat R/R PTCL. OBJECTIVE: As the distribution of PTCL subtypes differs between...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Target Oncol
Main Authors: Hong, Xiaonan, Song, Yuqin, Huang, Huiqiang, Bai, Bing, Zhang, Huilai, Ke, Xiaoyan, Shi, Yuankai, Zhu, Jun, Lu, Guodong, Liebscher, Stefan, Cai, Chunxiao
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2019
Assuntos:
Original Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6453867/
https://ncbi.nlm.nih.gov/pubmed/30904980
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11523-019-00630-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados